Public health insurance and cancer-specific mortality risk among patients with breast cancer: a prospective cohort study in China

Author:

Xie yuxin1,Valdimarsdóttir Unnur A.2,Wang Chengshi3,Zhong XiaoRong4,Gou Qiheng4,Zheng Hong4,Deng Ling4,He Ping4,Hu Kejia2,Fall Katja2,Fang Fang2,Tamimi Rulla M.5,Luo Ting4,Lu DonghaoORCID

Affiliation:

1. Department of Medical Oncology of Cancer Center, West China Hospital

2. Karolinska Institutet

3. Laboratory of Molecular Diagnosis of Cancer, Clinical Research Center for Breast

4. Sichuan University West China Hospital

5. Harvard University T H Chan School of Public Health

Abstract

Abstract Background Little is known about how health insurance policies, particularly in developing countries, may influence breast cancer prognosis. We aimed to examine the association between individual health insurance plans and breast cancer-specific mortality among patients in China.Methods We included 7,436 women diagnosed with invasive breast cancer between January 1 st , 2009, and December 31 st , 2016, at West China Hospital, Sichuan University. The health insurance plan of each patient was classified as either urban or rural schemes and was also categorized as reimbursement rate (i.e., the covered/ total charge) below or above the median. Breast cancer-specific mortality was the primary outcome. Using Cox proportional hazards models, we calculated hazard ratios (HRs) for cancer-specific mortality, contrasting rates among patients with a rural insurance scheme or low reimbursement rate to that of those with an urban insurance scheme or high reimbursement rate, respectively.Results During the median follow-up of 3.1 years, we identified 326 deaths due to breast cancer. Compared with patients covered by urban insurance schemes, patients covered by rural insurance schemes had a 29% increased cancer-specific mortality (95% CI 0% to 65%, P=0.046) after adjusting for demographics, tumor characteristics, and treatment modes. Reimbursement rate below the median was associated with a 42% increased rate of cancer-specific mortality (95% CI 11% to 82%). Every 10% increase in the reimbursement rate is associated with a 7% (95% CI, 2% to 12%) reduction in cancer-specific mortality risk, particularly in patients covered by rural insurance schemes (26%, 95% CI 9% to 39%).Conclusions Our findings suggest that under-insured patients with breast cancer in China face increased breast cancer-specific mortality, which may provide fresh insights into the role of reimbursement rate in cancer health disparities.

Publisher

Research Square Platform LLC

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3